- Supply chain disruptions
- Minimizing environmental impact of research activities (emissions of organic solvents).
Ryvu Therapeutics S.A.
Greenhouse gas emissions & sustainability report data
In its 2023 reporting, Ryvu Therapeutics S.A. disclosed greenhouse gas emissions of 1.6K Mg CO2 (2023). Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
1.6K Mg CO2 (2023)
2023
Water Usage
3.7K m3 (2023)
2023
Waste
33.1 tons (2023)
2023
Energy Use
2.4K MWh (2023)
2023
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2023 | 1.6K Mg CO2 (2023) |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- Relocated to a new energy-efficient R&D center with features like high-efficiency glass facade, heat exchangers, LED lighting, and a photovoltaic installation.
- Implemented water conservation measures in the new R&D center, including energy-efficient taps and toilets.
- Established a Ryvu garden using recycled materials, promoting employee engagement and environmental stewardship.
- 100% recycling of chlorinated waste.
🎯 Climate & Sustainability Targets
🔜 Short-term
- Proper waste segregation and management, including the concept of a circular economy and increasing the fraction of waste for recovery or recycling (within 3 years).
- Strict supervision over the use of chemical reagents (within 3 years).
- Optimization of media consumption, including drinking water, electricity, heat, and fuels (within 3 years).
📅 Medium-term
- Reducing the carbon footprint, mainly by reducing electricity consumption (within 3 years).
- Educating employees and engaging them in initiatives aimed at environmental protection (within 3 years).
🌱 ESG Focus Areas
Corporate GovernanceSocial ResponsibilityEnvironmental Sustainability